Literature DB >> 4569058

Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.

J J Lokich, A T Skarin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4569058

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  4 in total

1.  Chemotherapy of pancreatic carcinoma.

Authors:  J H Harvey; P S Schein
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

Review 2.  Progress report. Cytotoxic therapy for gastrointestinal carcinoma.

Authors:  T J Prostman
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

Review 3.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the pancreas.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-06       Impact factor: 1.798

4.  Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU).

Authors:  J Lokich; P L Chawla; J Brooks; E Frei
Journal:  Ann Surg       Date:  1974-04       Impact factor: 12.969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.